Surprisingly, these animals are protected from the development of obesity-associated deterioration of glucose metabolism, thereby defining insulin action in inflammatory cells as a novel and promising target for therapeutic intervention against obesity-associated diabetes mellitus. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.